Cargando…

Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation

Novel multitarget-directed ligands BIGI 4a-d and BIGI 5a-d were designed and synthesized with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction targeting acetyl-/butyrylcholinesterases inhibition, calcium channel antagonism, and antioxidant ability. Among these m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malek, Rim, Simakov, Alexey, Davis, Audrey, Maj, Maciej, Bernard, Paul J., Wnorowski, Artur, Martin, Helene, Marco-Contelles, José, Chabchoub, Fakher, Dallemagne, Patrick, Rochais, Christophe, Jozwiak, Krzysztof, Ismaili, Lhassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822022/ https://www.ncbi.nlm.nih.gov/pubmed/36615267 http://dx.doi.org/10.3390/molecules28010071

Ejemplares similares

Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
por: Dakhlaoui, Imen, et al.
Publicado: (2023)

Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives
por: Pachón Angona, Irene, et al.
Publicado: (2020)

Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
por: Pachòn Angona, Irene, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
por: Choura, Emna, et al.
Publicado: (2022)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

Biginelli Reaction Catalyzed by Copper Nanoparticles
por: Dewan, Manika, et al.
Publicado: (2012)

New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation
por: Bortolami, Martina, et al.
Publicado: (2021)

26th Annual GP2A Medicinal Chemistry Conference & 32nd Journées Franco-Belges de Pharmacochimie
por: Dallemagne, Patrick, et al.
Publicado: (2019)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Synthesis and Characterization of Dihydrouracil Analogs Utilizing Biginelli Hybrids
por: Bukhari, Syed Nasir Abbas, et al.
Publicado: (2022)

C3-Symmetric Ligands in Drug Design: When the Target Controls the Aesthetics of the Drug
por: Antonijevic, Mirjana, et al.
Publicado: (2023)

Inducing neuronal regeneration and differentiation via the BDNF/TrkB signaling pathway: a key target against neurodegenerative diseases?
por: Antonijevic, Mirjana, et al.
Publicado: (2023)

A mini-review on Biginelli adducts with notable pharmacological properties
por: de Fátima, Ângelo, et al.
Publicado: (2015)

A Five-Component Biginelli-Diels-Alder Cascade Reaction
por: Maskrey, Taber S., et al.
Publicado: (2018)

Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer’s Disease
por: Guiselin, Thomas, et al.
Publicado: (2023)

Eutectic Salt Catalyzed Environmentally Benign and Highly Efficient Biginelli Reaction
por: Azizi, Najmadin, et al.
Publicado: (2012)

Green Approach—Multicomponent Production of Boron—Containing Hantzsch and Biginelli Esters
por: Martínez, Joel, et al.
Publicado: (2013)

Biginelli Reaction Mediated Synthesis of Antimicrobial Pyrimidine Derivatives and Their Therapeutic Properties
por: Marinescu, Maria
Publicado: (2021)

Design, Synthesis, and Bioevaluation of Indole Core Containing 2-Arylidine Derivatives of Thiazolopyrimidine as Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A/B for the Treatment of Alzheimer Disease
por: Shahid Nadeem, Muhammad, et al.
Publicado: (2022)

5-Amino-3-methyl-1-phenyl-1H-1,2,4-triazole
por: Allouch, Fatma, et al.
Publicado: (2008)

Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation
por: Wnorowski, Artur, et al.
Publicado: (2021)

Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies
por: Pravin, Narayanaperumal, et al.
Publicado: (2022)

Benzophenone Derivatives with Histamine H(3) Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease
por: Godyń, Justyna, et al.
Publicado: (2022)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy
por: Lecoutey, Cédric, et al.
Publicado: (2021)

N-Donor ligand activation of titanocene for the Biginelli reaction via the imine mechanism
por: Zheng, Shaohua, et al.
Publicado: (2018)

Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
por: Zakrocka, Izabela, et al.
Publicado: (2018)

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022)

Target Profile Prediction and Practical Evaluation of a Biginelli-Type Dihydropyrimidine Compound Library
por: Schneider, Petra, et al.
Publicado: (2011)

Simple Method of Preparation and Characterization of New Antifungal Active Biginelli Type Heterocyclic Compounds
por: Pothiraj, C., et al.
Publicado: (2008)

A microdroplet-accelerated Biginelli reaction: mechanisms and separation of isomers using IMS-MS
por: Sahota, Navneet, et al.
Publicado: (2019)

Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions
por: Sánchez-Sancho, Francisco, et al.
Publicado: (2022)

Stepping Further from Coupling Tools: Development of Functional Polymers via the Biginelli Reaction
por: Ma, Zeyu, et al.
Publicado: (2022)

Synthesis of structurally diverse 3,4-dihydropyrimidin-2(1H)-ones via sequential Biginelli and Passerini reactions
por: Boukis, Andreas C, et al.
Publicado: (2017)

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Ethyl 6-amino-5-cyano-4-isopropyl-2-methyl-4H-pyran-3-carboxylate
por: Messaâd, Mehdi, et al.
Publicado: (2008)

A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT(4)R) Agonist and Serotonergic Subtype 6 Receptor (5-HT(6)R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease
por: Hatat, Bérénice, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_euldebit6ae98le91evu54lc5j